Welcome to Diazyme Laboratories - Innovating Healthcare with Advanced Diagnostics

Diazyme Laboratories Inc., a leader in innovative diagnostic solutions, is dedicated to advancing healthcare through proprietary enzyme and immunoassay technologies. We specialize in the research and development, manufacture, and distribution of accurate, high-quality diagnostic reagents that can be used on user-friendly automated analyzers. With a commitment to excellence, our cutting-edge products are trusted by healthcare professionals worldwide.

New Arrivals

ApoE4 Test Kit COMING SOON

ApoE4 Test Kit

Coming Soon! INTENDED USE: The Diazyme ApoE4 Test Kit is designed to qualitatively determine the presence of ApoE4 antigens in human plasma. The test allows to determine if a sample is ApoE4 negative...

Request Quote
pTau-217 CLIA KIT COMING SOON

pTau-217 CLIA KIT

Coming Soon! INTENDED USE: Diazyme pTau-217 CLIA Kit is for the quantitative determination of Phosphorylated Tau 217 (pTau-217) concentration in EDTA plasma on chemiluminescence analyzer. USA: For...

Request Quote
AMYLOID-β42 CLIA KIT COMING SOON

AMYLOID-β42 CLIA KIT

Coming Soon! INTENDED USE: Diazyme Aβ42 CLIA Kit is for the quantitative determination of Aβ42 concentration in EDTA plasma on chemiluminescence analyzer. USA: For Research Use Only. Not for use in...

Request Quote
AMYLOID-β40 CLIA KIT COMING SOON

AMYLOID-β40 CLIA Kit

Coming Soon! INTENDED USE: Diazyme Aβ40 CLIA Kit is for the quantitative determination of Aβ40 concentration in EDTA plasma on chemiluminescence analyzer. USA: For Research Use Only. Not for use in...

Request Quote
pTau-181 Assay COMING SOON

pTau-181 CLIA KIT

Coming Soon! INTENDED USE: Diazyme pTau-181 CLIA Kit is for the quantitative determination of Phosphorylated Tau 181 (pTau-181) concentration in EDTA plasma on chemiluminescence analyzer. USA: For...

Request Quote

Products View all

Recent Announcements

Webinar Recap: Kappa and Lambda Free Light Chains in Plasma Cell Disorders

22nd Apr 2026

Abbott recently hosted a webinar exploring the clinical role of kappa and lambda free light chain te…
read more

Diazyme Laboratories, Inc. Announces FDA 501(k) Clearance for MGUS for Kappa and Lambda Free Light Chain Assays

14th Jan 2026

SAN DIEGO, CA - January 14, 2026 - Diazyme Laboratories, Inc. announces receiving 510(k) clearance f…
read more

FDA Grants 510(k) Clearance to the Diazyme Colorimetric Lithium Assay

30th Dec 2025

SAN DIEGO, CA - 30 December 2025 - Diazyme Laboratories, Inc. today announced that the U.S. Food and…
read more